The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines.

Weilong Shang Yi YangYifan RaoXiancai Rao

Published in: NPJ vaccines (2020)

The outbreak of 2019-novel coronavirus disease (COVID-19) that is caused by SARS-CoV-2 has spread rapidly in China, and has developed to be a Public Health Emergency of International Concern. However, no specific antiviral treatments or vaccines are available yet. This work aims to share strategies and candidate antigens to develop safe and effective vaccines against SARS-CoV-2.

Keyphrases

sars cov
public health
respiratory syndrome coronavirus
coronavirus disease
emergency department
healthcare
dendritic cells
intensive care unit
immune response